PARP1, CPTAC-556 - CPTAC Assay Portal (original) (raw)

Please include the following statement when referencing the CPTAC Assay Portal

We would like to acknowledge the National Cancer Institute’s Clinical Proteomic Tumor Analysis Consortium (CPTAC) Assay Portal (assays.cancer.gov) for developing assays and establishing criteria for the assays described in this publication.

Protein Sequence hover to view complete sequence

10 20 30 40 50
MAESSDKLYR VEYAKSGRAS CKKCSESIPK DSLRMAIMVQ SPMFDGKVPH
60 70 80 90 100
WYHFSCFWKV GHSIRHPDVE VDGFSELRWD DQQKVKKTAE AGGVTGKGQD
110 120 130 140 150
GIGSKAEKTL GDFAAEYAKS NRSTCKGCME KIEKGQVRLS KKMVDPEKPQ
160 170 180 190 200
LGMIDRWYHP GCFVKNREEL GFRPEYSASQ LKGFSLLATE DKEALKKQLP
210 220 230 240 250
GVKSEGKRKG DEVDGVDEVA KKKSKKEKDK DSKLEKALKA QNDLIWNIKD
260 270 280 290 300
ELKKVCSTND LKELLIFNKQ QVPSGESAIL DRVADGMVFG ALLPCEECSG
310 320 330 340 350
QLVFKSDAYY CTGDVTAWTK CMVKTQTPNR KEWVTPKEFR EISYLKKLKV
360 370 380 390 400
KKQDRIFPPE TSASVAATPP PSTASAPAAV NSSASADKPL SNMKILTLGK
410 420 430 440 450
LSRNKDEVKA MIEKLGGKLT GTANKASLCI STKKEVEKMN KKMEEVKEAN
460 470 480 490 500
IRVVSEDFLQ DVSASTKSLQ ELFLAHILSP WGAEVKAEPV EVVAPRGKSG
510 520 530 540 550
AALSKKSKGQ VKEEGINKSE KRMKLTLKGG AAVDPDSGLE HSAHVLEKGG
560 570 580 590 600
KVFSATLGLV DIVKGTNSYY KLQLLEDDKE NRYWIFRSWG RVGTVIGSNK
610 620 630 640 650
LEQMPSKEDA IEHFMKLYEE KTGNAWHSKN FTKYPKKFYP LEIDYGQDEE
660 670 680 690 700
AVKKLTVNPG TKSKLPKPVQ DLIKMIFDVE SMKKAMVEYE IDLQKMPLGK
710 720 730 740 750
LSKRQIQAAY SILSEVQQAV SQGSSDSQIL DLSNRFYTLI PHDFGMKKPP
760 770 780 790 800
LLNNADSVQA KVEMLDNLLD IEVAYSLLRG GSDDSSKDPI DVNYEKLKTD
810 820 830 840 850
IKVVDRDSEE AEIIRKYVKN THATTHNAYD LEVIDIFKIE REGECQRYKP
860 870 880 890 900
FKQLHNRRLL WHGSRTTNFA GILSQGLRIA PPEAPVTGYM FGKGIYFADM
910 920 930 940 950
VSKSANYCHT SQGDPIGLIL LGEVALGNMY ELKHASHISK LPKGKHSVKG
960 970 980 990 1000
LGKTTPDPSA NISLDGVDVP LGTGISSGVN DTSLLYNEYI VYDIAQVNLK
1010 1014
YLLKLKFNFK TSLW

Data source: UniProt


Position of Targeted Peptide Analytes Relative to SNPs, Isoforms, and PTMs

Uniprot Database Entry PhosphoSitePlus ®

Click a point on a node

to view detailed assay information below

All other points link out to UniProt


Phosphorylation Acetylation Ubiquitylation Other

loading

Loader


Assay Details for CPTAC-3240 Collapse assay details

Data source: Panorama

Official Gene Symbol

PARP1

Peptide Sequence

EELGFRPEYSASQLK

Modification Type

unmodified

Protein - Site of Modification

N/A

Peptide - Site of Modification

N/A

Peptide Start

168

Peptide End

182

CPTAC ID

CPTAC-3240

Peptide Molecular Mass

1,752.8683

Species

Homo sapiens (Human)

Assay Type

Enrichment MRM

Enrichment Method

N/A

Matrix

cell lysate

Submitting Laboratory

Fred Hutchinson Cancer Research Center

Submitting Lab PI

Amanda Paulovich


Publication

View Details (opens in a new window)

A Multiplexed Mass Spectrometry-Based Assay for Robust Quantification of Phosphosignaling in Response to DNA Damage. Whiteaker JR, Zhao L, Saul R, Kaczmarczyk JA, Schoenherr RM, Moore HD, Jones-Weinert C, Ivey RG, Lin C, Hiltke T, Reding KW, Whiteley G, Wang P, Paulovich AG. Radiat Res. 2018 Feb 23. doi: 10.1667/RR14963.1. [Epub ahead of print]


Assay Parameters Collapse assay parameters

Data source: Panorama

Instrument

6500 QTRAP (Sciex)

Internal Standard

synthetic peptide

Peptide Standard Purity

>95%

Peptide Standard Label Type

13C and 15N at C-terminus K

LC

Ultra NanoLC 2D+ (Eksigent)

Column Packing

ReproSil-Pur C18-AQ 3um

Column Dimensions

100 x 0.075 mm

Flow Rate

300 uL/min


Chromatograms

Data source: Panorama


Response Curves

Data source: Panorama

Retrieving Data

Loader


Repeatability

Data source: Panorama

| | Average intra-assay CV(within day CV) | Average inter-assay CV(between day CV) | Total CVequation | n= | | | | | | | | | | | ---------------------------------------- | -------------------------------------- | --------------------------------------------------------------------------------- | -------- | ------- | ------- | -------- | ------- | ------- | -------- | ------- | ------- | -------- | | Fragment ion / Transition | Low | Med | High | Low | Med | High | Low | Med | High | Low | Med | High | | y11 (2+) | 15 | 7.7 | 13.7 | 21.4 | 12.8 | 15.5 | 26.1 | 14.9 | 20.7 | 15 | 15 | 15 | | y9 (1+) | 28.1 | 11.3 | 6.6 | 34.1 | 17.4 | 10.2 | 44.2 | 20.7 | 12.1 | 15 | 15 | 15 | | y12 (2+) | 11.4 | 11.2 | 9.4 | 35.9 | 18.4 | 10.7 | 37.7 | 21.5 | 14.2 | 15 | 15 | 15 | | y6 (1+) | 15.8 | 11.9 | 11.8 | 15.3 | 16.8 | 13.3 | 22 | 20.6 | 17.8 | 15 | 15 | 15 | | y5 (1+) | 34.1 | 10.7 | 10.8 | 35.9 | 14.5 | 15.3 | 49.5 | 18 | 18.7 | 15 | 15 | 15 | | sum | 10.6 | 8.1 | 8.3 | 22.5 | 13.3 | 10.5 | 24.9 | 15.6 | 13.4 | 15 | 15 | 15 |



Additional Resources and Comments


Assay Details for CPTAC-3241 Collapse assay details

Data source: Panorama

Official Gene Symbol

PARP1

Peptide Modified Sequence

EELGFRPEYS[+80.0]ASQLK

Modification Type

Phospho (ST)

Protein - Site of Modification

177

Peptide - Site of Modification

10

Peptide Start

168

Peptide End

182

CPTAC ID

CPTAC-3241

Peptide Molecular Mass

1,832.8346

Species

Homo sapiens (Human)

Assay Type

Enrichment MRM

Enrichment Method

N/A

Matrix

cell lysate

Submitting Laboratory

Fred Hutchinson Cancer Research Center

Submitting Lab PI

Amanda Paulovich


Publication

View Details (opens in a new window)

A Multiplexed Mass Spectrometry-Based Assay for Robust Quantification of Phosphosignaling in Response to DNA Damage. Whiteaker JR, Zhao L, Saul R, Kaczmarczyk JA, Schoenherr RM, Moore HD, Jones-Weinert C, Ivey RG, Lin C, Hiltke T, Reding KW, Whiteley G, Wang P, Paulovich AG. Radiat Res. 2018 Feb 23. doi: 10.1667/RR14963.1. [Epub ahead of print]


Assay Parameters Collapse assay parameters

Data source: Panorama

Instrument

6500 QTRAP (Sciex)

Internal Standard

synthetic peptide

Peptide Standard Purity

>95%

Peptide Standard Label Type

13C and 15N at C-terminus K

LC

Ultra NanoLC 2D+ (Eksigent)

Column Packing

ReproSil-Pur C18-AQ 3um

Column Dimensions

100 x 0.075 mm

Flow Rate

300 uL/min


Chromatograms

Data source: Panorama


Response Curves

Data source: Panorama

Retrieving Data

Loader


Repeatability

Data source: Panorama

| | Average intra-assay CV(within day CV) | Average inter-assay CV(between day CV) | Total CVequation | n= | | | | | | | | | | | ---------------------------------------- | -------------------------------------- | --------------------------------------------------------------------------------- | -------- | ------- | ------- | -------- | ------- | ------- | -------- | ------- | ------- | -------- | | Fragment ion / Transition | Low | Med | High | Low | Med | High | Low | Med | High | Low | Med | High | | y9-98 (2+) | 42.1 | 31.1 | 17.9 | 48.3 | 67.4 | 28.1 | 64.1 | 74.2 | 33.3 | 15 | 15 | 15 | | y9-98 (1+) | 46.9 | 27.1 | 24.5 | 72.3 | 61.6 | 53.4 | 86.2 | 67.3 | 58.8 | 15 | 15 | 15 | | y9 (2+) | 27.7 | 19.8 | 21.4 | 42.9 | 28.7 | 29.5 | 51.1 | 34.9 | 36.4 | 15 | 15 | 15 | | y13 (2+) | 27.4 | 14.6 | 19.1 | 38.8 | 14.7 | 20.9 | 47.5 | 20.7 | 28.3 | 15 | 15 | 15 | | sum | 21.8 | 11.6 | 14 | 22.6 | 16.2 | 17.6 | 31.4 | 19.9 | 22.5 | 15 | 15 | 15 |



Additional Resources and Comments


Assay Details for CPTAC-6223 Collapse assay details

Data source: Panorama

Official Gene Symbol

PARP1

Peptide Sequence

EELGFRPEYSASQLK

Modification Type

unmodified

Protein - Site of Modification

N/A

Peptide - Site of Modification

7

Peptide Start

168

Peptide End

182

CPTAC ID

CPTAC-6223

Peptide Molecular Mass

1,752.8683

Species

Homo Sapiens

Assay Type

Enrichment MRM

Enrichment Method

N/A

Matrix

Frozen tissue

Submitting Laboratory

Fred Hutchinson Cancer Research Center

Submitting Lab PI

Amanda Paulovich


Assay Parameters Collapse assay parameters

Data source: Panorama

Instrument

QTRAP 5500

Internal Standard

Extended heavy peptide

Peptide Standard Purity

>95%

Peptide Standard Label Type

13C and 15N at C-terminus K

LC

Eksigent

Column Packing

Reprosil C18, 3um

Column Dimensions

75µm x 15cm

Flow Rate

0.3 µL/min


Chromatograms

Data source: Panorama


Response Curves

Data source: Panorama

Retrieving Data

Loader


Repeatability

Data source: Panorama

| | Average intra-assay CV(within day CV) | Average inter-assay CV(between day CV) | Total CVequation | n= | | | | | | | | | | | ---------------------------------------- | -------------------------------------- | --------------------------------------------------------------------------------- | -------- | ------- | ------- | -------- | ------- | ------- | -------- | ------- | ------- | -------- | | Fragment ion / Transition | Low | Med | High | Low | Med | High | Low | Med | High | Low | Med | High | | y6 (1+) | 6.6 | 3.1 | 3.1 | 10.3 | 10.6 | 6.7 | 12.2 | 11 | 7.4 | 15 | 15 | 15 | | y5 (1+) | 4.2 | 4.2 | 2.6 | 11.6 | 5.8 | 6.3 | 12.3 | 7.2 | 6.8 | 15 | 15 | 15 | | y11 (2+) | 6.3 | 4.5 | 2.4 | 13.1 | 6.4 | 4.8 | 14.5 | 7.8 | 5.4 | 15 | 15 | 15 | | y12 (2+) | 5.6 | 3.2 | 3.5 | 15.5 | 6.2 | 4.7 | 16.5 | 7 | 5.9 | 15 | 15 | 15 | | sum | 4.8 | 2.9 | 2.9 | 13.8 | 6.1 | 4.7 | 14.6 | 6.8 | 5.5 | 15 | 15 | 15 |



Additional Resources and Comments


Assay Details for CPTAC-5899 Collapse assay details

Data source: Panorama

Official Gene Symbol

PARP1

Peptide Modified Sequence

MAIMVQS[+79.966331]PMFDGK

Modification Type

Phospho (ST)

Protein - Site of Modification

42

Peptide - Site of Modification

7

Peptide Start

35

Peptide End

47

CPTAC ID

CPTAC-5899

Peptide Molecular Mass

1,533.6431

Species

Homo sapiens (Human)

Assay Type

Enrichment MRM

Enrichment Method

N/A

Matrix

Cell Lysate

Submitting Laboratory

Fred Hutchinson Cancer Research Center

Submitting Lab PI

Amanda Paulovich


Publication

View Details (opens in a new window)

Targeted Mass Spectrometry Enables Quantification of Novel Pharmacodynamic Biomarkers of ATM Kinase Inhibition. Whiteaker JR, Wang T, Zhao L, Schoenherr RM, Kennedy JJ, Voytovich U, Ivey RG, Huang D, Lin C, Colantonio S, Caceres TW, Roberts RR, Knotts JG, Kaczmarczyk JA, Blonder J, Reading JJ, Richardson CW, Hewitt SM, Garcia-Buntley SS, Bocik W, Hiltke T, Rodriguez H, Harrington EA, Barrett JC, Lombardi B, Marco-Casanova P, Pierce AJ, Paulovich AG. Cancers (Basel). 2021 Jul 30;13(15):3843. doi: 10.3390/cancers13153843. PMID: 34359745


Assay Parameters Collapse assay parameters

Data source: Panorama

Instrument

Sciex 5500 QTRAP

Internal Standard

peptide

Peptide Standard Purity

>95%

Peptide Standard Label Type

13C and 15N at C-terminus K

LC

Eksigent 425

Column Packing

Reprosil

Column Dimensions

75um x 15cm

Flow Rate

300 nL/min


Chromatograms

Data source: Panorama


Response Curves

Data source: Panorama

Retrieving Data

Loader


Repeatability

Data source: Panorama

| | Average intra-assay CV(within day CV) | Average inter-assay CV(between day CV) | Total CVequation | n= | | | | | | | | | | | ---------------------------------------- | -------------------------------------- | --------------------------------------------------------------------------------- | -------- | ------- | ------- | -------- | ------- | ------- | -------- | ------- | ------- | -------- | | Fragment ion / Transition | Low | Med | High | Low | Med | High | Low | Med | High | Low | Med | High | | y6 (1+) | 48.6 | 24.5 | 11.2 | 74.6 | 26.3 | 18.8 | 89 | 35.9 | 21.9 | 15 | 27 | 15 | | y4 (1+) | 48.8 | 41.3 | 16 | 61.8 | 44.5 | 13.2 | 78.7 | 60.7 | 20.7 | 15 | 27 | 15 | | b4 (1+) | 54.4 | 31.9 | 19.5 | 57.4 | 39.1 | 20.3 | 79.1 | 50.5 | 28.1 | 15 | 27 | 15 | | b5 (1+) | 41.3 | 28.3 | 11.6 | 37.9 | 30.5 | 25 | 56.1 | 41.6 | 27.6 | 15 | 27 | 15 | | y10 (1+) | 73.3 | 20.4 | 13.4 | 71.8 | 24.4 | 20.1 | 102.6 | 31.8 | 24.2 | 15 | 27 | 15 | | y9 (1+) | 66.3 | 26.6 | 18.8 | 85.4 | 29.8 | 19.5 | 108.1 | 39.9 | 27.1 | 15 | 27 | 15 | | y7 (1+) | 71.7 | 35.5 | 9.9 | 65.2 | 37.3 | 22.2 | 96.9 | 51.5 | 24.3 | 15 | 27 | 15 | | sum | 27.5 | 13.9 | 7.5 | 41.3 | 20 | 14.6 | 49.6 | 24.4 | 16.4 | 15 | 27 | 15 |



Additional Resources and Comments


Assay Details for CPTAC-557 Collapse assay details

Data source: Panorama

Official Gene Symbol

PARP1

Peptide Sequence

TTNFAGILSQGLR

Modification Type

unmodified

Protein - Site of Modification

N/A

Peptide - Site of Modification

N/A

Peptide Start

866

Peptide End

878

CPTAC ID

CPTAC-557

Peptide Molecular Mass

1,376.7412

Species

Homo sapiens (Human)

Assay Type

Direct MRM

Matrix

cell line lysate pool

Submitting Laboratory

Seoul National University / Korea Institute of Science and Technology and FHCRC

Submitting Lab PI

Youngsoo Kim


Publication

View Details (opens in a new window)

Demonstrating the feasibility of large-scale development of standardized assays to quantify human proteins. Kennedy JJ, Abbatiello SE, Kim K, Yan P, Whiteaker JR, Lin C, Kim JS, Zhang Y, Wang X, Ivey RG, Zhao L, Min H, Lee Y, Yu MH, Yang EG, Lee C, Wang P, Rodriguez H, Kim Y, Carr SA, Paulovich AG. Nat Methods. 2014 Feb;11(2):149-55. doi: 10.1038/nmeth.2763. Epub 2013 Dec 8. PMID: 24317253


Response curves acquired at Seoul National University / Korea Institute of Science and Technology. Repeatability data acquired at Fred Hutchinson Cancer Research Center.


Response curves acquired at Seoul National University / Korea Institute of Science and Technology. Repeatability data acquired at Fred Hutchinson Cancer Research Center.


Assay Parameters Collapse assay parameters

Data source: Panorama

Instrument

5500 QTRAP (ABSCIEX)

Internal Standard

peptide

Peptide Standard Purity

>95%

Peptide Standard Label Type

13C,15N

LC

nanoLC-Ultra 2D, cHiPLC-nanoflex (Eksigent)

Column Packing

ChromXP C18-CL, 3 um, 120A

Column Dimensions

150 x 0.075 mm

Flow Rate

500 nL / min


Chromatograms

Data source: Panorama


Response Curves

Data source: Panorama

Retrieving Data

Loader


Repeatability

Data source: Panorama

| | Average intra-assay CV(within day CV) | Average inter-assay CV(between day CV) | Total CVequation | n= | | | | | | | | | | | ---------------------------------------- | -------------------------------------- | --------------------------------------------------------------------------------- | -------- | ------- | ------- | -------- | ------- | ------- | -------- | ------- | ------- | -------- | | Fragment ion / Transition | Low | Med | High | Low | Med | High | Low | Med | High | Low | Med | High | | y9 (1+) | 12.9 | 4.4 | 4.4 | 17.1 | 6.9 | 5.6 | 21.4 | 8.2 | 7.1 | 15 | 25 | 15 | | y8 (1+) | 8.2 | 5.9 | 3.5 | 14.5 | 8.1 | 4.3 | 16.7 | 10 | 5.5 | 15 | 25 | 15 | | y7 (1+) | 34.5 | 18.4 | 28.2 | 32.7 | 22.5 | 49.1 | 47.5 | 29.1 | 56.6 | 15 | 25 | 15 | | sum | 8.3 | 5.2 | 3.2 | 12.8 | 6.8 | 4.9 | 15.3 | 8.6 | 5.9 | 15 | 25 | 15 |



Additional Resources and Comments


Assay Details for CPTAC-556 Collapse assay details

Data source: Panorama

Official Gene Symbol

PARP1

Peptide Sequence

VVSEDFLQDVSASTK

Modification Type

unmodified

Protein - Site of Modification

N/A

Peptide - Site of Modification

N/A

Peptide Start

453

Peptide End

467

CPTAC ID

CPTAC-556

Peptide Molecular Mass

1,623.7992

Species

Homo sapiens (Human)

Assay Type

Direct MRM

Matrix

cell line lysate pool

Submitting Laboratory

Seoul National University / Korea Institute of Science and Technology and FHCRC

Submitting Lab PI

Youngsoo Kim


Publication

View Details (opens in a new window)

Demonstrating the feasibility of large-scale development of standardized assays to quantify human proteins. Kennedy JJ, Abbatiello SE, Kim K, Yan P, Whiteaker JR, Lin C, Kim JS, Zhang Y, Wang X, Ivey RG, Zhao L, Min H, Lee Y, Yu MH, Yang EG, Lee C, Wang P, Rodriguez H, Kim Y, Carr SA, Paulovich AG. Nat Methods. 2014 Feb;11(2):149-55. doi: 10.1038/nmeth.2763. Epub 2013 Dec 8. PMID: 24317253


Response curves acquired at Seoul National University / Korea Institute of Science and Technology. Repeatability data acquired at Fred Hutchinson Cancer Research Center.


Response curves acquired at Seoul National University / Korea Institute of Science and Technology. Repeatability data acquired at Fred Hutchinson Cancer Research Center.


Assay Parameters Collapse assay parameters

Data source: Panorama

Instrument

5500 QTRAP (ABSCIEX)

Internal Standard

peptide

Peptide Standard Purity

>95%

Peptide Standard Label Type

13C,15N

LC

nanoLC-Ultra 2D, cHiPLC-nanoflex (Eksigent)

Column Packing

ChromXP C18-CL, 3 um, 120A

Column Dimensions

150 x 0.075 mm

Flow Rate

500 nL / min


Chromatograms

Data source: Panorama


Response Curves

Data source: Panorama

Retrieving Data

Loader


Repeatability

Data source: Panorama

| | Average intra-assay CV(within day CV) | Average inter-assay CV(between day CV) | Total CVequation | n= | | | | | | | | | | | ---------------------------------------- | -------------------------------------- | --------------------------------------------------------------------------------- | -------- | ------- | ------- | -------- | ------- | ------- | -------- | ------- | ------- | -------- | | Fragment ion / Transition | Low | Med | High | Low | Med | High | Low | Med | High | Low | Med | High | | y11 (1+) | 26 | 10.4 | 7.4 | 25.5 | 14.9 | 10.9 | 36.4 | 18.2 | 13.2 | 15 | 25 | 15 | | y9 (1+) | 15.9 | 7.1 | 6.9 | 20.7 | 7.8 | 10.2 | 26.1 | 10.5 | 12.3 | 15 | 25 | 15 | | y8 (1+) | 38.1 | 9.2 | 3.8 | 36 | 10.8 | 7.3 | 52.4 | 14.2 | 8.2 | 15 | 25 | 15 | | sum | 18.2 | 7.2 | 2.1 | 16.8 | 9.5 | 6.3 | 24.8 | 11.9 | 6.6 | 15 | 25 | 15 |



Additional Resources and Comments